Perspective Therapeutics (CATX) Other Accumulated Expenses (2011 - 2023)

Perspective Therapeutics has disclosed Other Accumulated Expenses across 13 years of filings, most recently posting $480000.0 for Q4 2023.

• In Q4 2023, Other Accumulated Expenses fell 15.94% year-over-year to $480000.0; the TTM figure through Dec 2023 stood at $480000.0 (down 15.94% YoY), while the FY2023 annual figure was $480000.0, down 15.94% from the prior year.
• Other Accumulated Expenses came in at $480000.0 for Q4 2023 at Perspective Therapeutics, up from $24000.0 in the prior quarter.
• In the past five years, Other Accumulated Expenses ranged from a high of $571000.0 in Q4 2022 to a low of $15000.0 in Q1 2023.
• Average Other Accumulated Expenses over 5 years is $127300.0, with a median of $96500.0 recorded in 2020.
• Year-over-year, Other Accumulated Expenses jumped 454.37% in 2022 and slumped 84.04% in 2023.
• Over 5 years, Other Accumulated Expenses stood at $89000.0 in 2019, then advanced by 13.48% to $101000.0 in 2020, then increased by 1.98% to $103000.0 in 2021, then jumped by 454.37% to $571000.0 in 2022, then decreased by 15.94% to $480000.0 in 2023.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $480000.0 in Q4 2023, $24000.0 in Q3 2023, and $20000.0 in Q2 2023.